The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
about
5-HT3 receptorsEffects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxietyOrganisation of the murine 5-HT3 receptor gene and assignment to human chromosome 11Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activityOpen probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancySocial isolation modifies nicotine's effects in animal tests of anxietyThe age of anxiety: role of animal models of anxiolytic action in drug discovery.GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures.5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze.BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety.The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.Anxiolytic potential of 5-HT3 receptor antagonists.Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?Distribution of serotonin receptors.Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology.Serotonin function and human anxiety disorders.Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.Clinical pharmacokinetics of ondansetron. A review.Serotonin 5-HT3 and 5-HT4 receptor antagonists.Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.Molecular size of the 5-HT3 receptor solubilized from NCB 20 cellsThe mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats.Intravenous granisetron attenuates hypotension during spinal anesthesia in cesarean delivery: A double-blind, prospective randomized controlled study.The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbensThe properties of 5-HT3 receptors in clonal cell lines studied by patch-clamp techniques.Tuned methods for conjugate addition to a vinyl oxadiazole; synthesis of pharmaceutically important motifs.8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition.Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro.Evaluation of anxiolytic action of ondansetron in rats during withdrawal from chronic chlordiazepoxide.
P2860
Q24648000-891294ED-F9D8-407E-B462-30D19AA07C2CQ24679647-0F379EAD-8534-43D4-83B0-851BA8D672D8Q28249845-B63E88EC-4277-45CD-A2C4-A9A22F031723Q28334293-478B4352-40A0-48DD-8278-527953518136Q28348762-C99D2BA8-17DD-412F-AD1D-686E93056765Q28361172-FD9C7753-6932-469E-B8AC-4CA35E4F3AD0Q30462832-FF1238A8-4EF9-4EE1-A7B8-B2C18F5AC7EAQ33248595-869BCB51-6B2A-4C7B-8621-EB8C8FE381AFQ34243207-710DA3FE-92D6-4C0E-8178-F68EEB67F87BQ34296353-D4A26EA6-5A2C-4EA7-9F34-AF6990BD0E91Q34316825-E29C5EE5-F598-4243-BE39-4CCCD6DE97B9Q34369831-C6860D4C-1AFE-48E9-A85B-5FFB4FB0C25AQ34541188-63E172E0-611F-420F-87EB-CED6E7F78981Q35026883-AA6C34AA-EFC9-47C2-8688-6B12C9709AE8Q35254635-5FF59E02-088B-429D-B0DC-63E1A936CD76Q35275821-D9B131D9-181D-469E-B7C3-06CDCC480198Q35756196-A4817E83-BAD3-49D8-9185-6DA5DD521ECFQ37685759-D92478A3-8B75-4347-BDE3-DCB6289B7621Q38004444-C346DA17-DD57-44D5-83CE-6903A9FB5622Q38004460-47A0AC28-8AB8-41D4-A129-DF1095DCFC13Q38004479-12A8B608-DD03-4FA8-A788-46836DD9053BQ40548169-05E32F0B-F142-436B-9C15-0EA6D4C09302Q40576772-F0289963-5DE0-403E-85F9-1D7EEB1F3716Q40601504-E2AF9E39-1E5A-436F-8D3B-9E0D7F8B50D0Q41184687-29E1DED7-F268-455D-9E7F-A6D0CF4BF8B7Q41370406-65AB9343-2EE1-4272-83EB-867E48A3693BQ41689855-92D50EFC-7F17-4E4E-8BEB-FC7FAAC428CCQ41840952-67BC1BC3-7B8C-4F46-BD20-F64C615F0089Q41975567-1D41E84E-6B44-4082-9694-279D538E468AQ41991056-ECEF05B7-1A18-43B4-AC57-51A7965ADE1CQ42277669-58F3BDEE-ADBD-4C10-98E6-43200959CB67Q42605957-D1F95B19-C925-4037-AA4F-6412B2533BC2Q42710910-9141FB63-BE86-44DA-AB8C-EE53C89C9705Q42716106-4827C20D-2FC6-405C-83D1-042D8351B29CQ42847952-738CFD89-9889-46DF-8A74-36D4C7EED465Q43083316-1B3376B6-6431-4929-95C2-E422F1373785Q43521690-D2A85B60-33B4-4163-81F6-BC7E4721367EQ43621839-5D16D4AA-9734-4CEE-B5B2-B1174D671B1BQ43737841-B4B7CCEB-9640-4ABB-AC93-78C885DFF5A0Q43864129-A742CB8C-55D5-4981-87A1-CFF0B028DEDD
P2860
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
@ast
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
@en
type
label
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
@ast
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
@en
prefLabel
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
@ast
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
@en
P2093
P2860
P1476
The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
@en
P2093
Domeney AM
P2860
P304
P356
10.1111/J.1476-5381.1988.TB11489.X
P407
P577
1988-04-01T00:00:00Z